Medical devices, healthcare technology and the business of care
510(k) clearance · K262828

KHEIRON Spinal Fixation System, including patient specific K-ROD

S.M.A.I.O · Decision date Sep 4, 2026

MEDTECHLEDGER EXPLANATIONK262828

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-04 for K262828, a 510(k) premarket notification submitted by S.M.A.I.O of Saint-Priest, France, with BioVera, Inc. as correspondent. The device is the KHEIRON® Spinal Fixation System, including a patient specific K-ROD, classified as a Thoracolumbosacral Pedicle Screw System under 21 CFR 888.3070, product code NKB, with KWP listed as a subsequent product code. The application was received 08/10/2026, and the review panel and regulation medical specialty are both orthopedic.

SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The record shows a special summary, no third-party review, no combination product designation and no authorized predetermined change control plan. The public record does not state the predicate device, the specific design or material changes to the K-ROD, or any clinical performance data, so the basis for the equivalence finding and any patient-selection or use instructions remain in the FDA summary document rather than this listing.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 4, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262828
Regulatory pathway
510(k) premarket notification
Applicant
S.M.A.I.O
Product code
NKB
Decision code
SESE
Decision date
Sep 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Thoracolumbosacral Pedicle Screw System.

Applicant
S.M.A.I.O
Product code
NKB
FDA device class
2

FDA decision timeline

  1. K262828 received

    Application receipt date recorded by FDA.

  2. K262828 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NKB

Product / regulatory recordCompanyPathwayDecision dateSource
SeaSpine Orthopedics Corporation510(k) clearanceOct 29, 2026FDA
GS Medical Co., Ltd.510(k) clearanceOct 2, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 1, 2026FDA
Duet Spine Holdings, LLC510(k) clearanceSep 30, 2026FDA
Spinal Alignment Solutions, Inc.510(k) clearanceSep 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

S.M.A.I.O

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Saint-Priest

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records